|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
clobenpropit promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] |
CTD |
PMID:17196553 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
clobenpropit results in decreased expression of CCL2 protein |
CTD |
PMID:17507084 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[HRH4 protein results in increased susceptibility to clobenpropit] which results in decreased expression of CCND1 protein |
CTD |
PMID:22363581 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[HRH4 protein results in increased susceptibility to clobenpropit] which results in decreased expression of CDK2 protein |
CTD |
PMID:22363581 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1A protein |
CTD |
PMID:22363581 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein |
CTD |
PMID:22363581 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Hrh1 |
histamine receptor H 1 |
multiple interactions |
EXP |
[Pyrilamine binds to and results in decreased activity of HRH1 protein] which results in decreased susceptibility to clobenpropit |
CTD |
PMID:16488453 |
|
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
|
|
G |
Hrh2 |
histamine receptor H 2 |
multiple interactions |
ISO EXP |
HRH2 protein promotes the reaction [clobenpropit results in increased expression of IL16 protein] [Cimetidine binds to and results in decreased activity of HRH2 protein] which results in decreased susceptibility to clobenpropit |
CTD |
PMID:12235264 PMID:16488453 |
|
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
|
|
G |
Hrh3 |
histamine receptor H3 |
multiple interactions affects binding |
ISO EXP |
clobenpropit binds to and results in decreased activity of HRH3 protein; clobenpropit inhibits the reaction [[Methylhistamines binds to and results in increased activity of HRH3 protein] which results in increased transport of Calcium] clobenpropit analog binds to HRH3 protein; clobenpropit binds to HRH3 protein [4-(1H-imidazol-4-ylmethyl)piperidine binds to and results in increased activity of HRH3 protein] which results in decreased susceptibility to clobenpropit; [clobenpropit binds to and results in decreased activity of HRH3 protein] which results in decreased susceptibility to Scopolamine; clobenpropit binds to and results in decreased activity of HRH3 protein |
CTD |
PMID:12706455 PMID:16488453 PMID:22003888 |
|
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
|
|
G |
Hrh4 |
histamine receptor H4 |
multiple interactions affects binding increases response to substance |
ISO |
1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine inhibits the reaction [[clobenpropit binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium]; 1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine inhibits the reaction [HRH4 protein results in increased susceptibility to clobenpropit]; [clobenpropit binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium; [HRH4 protein results in increased susceptibility to clobenpropit] which results in decreased expression of CCND1 protein; [HRH4 protein results in increased susceptibility to clobenpropit] which results in decreased expression of CDK2 protein; [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1A protein; [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein; clobenpropit binds to and results in increased activity of HRH4 protein clobenpropit binds to HRH4 protein |
CTD |
PMID:17507084 PMID:22003888 PMID:22363581 |
|
NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Ifng |
interferon gamma |
affects expression |
ISO |
clobenpropit affects the expression of IFNG protein |
CTD |
PMID:17346280 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il16 |
interleukin 16 |
multiple interactions increases expression |
ISO |
HRH2 protein promotes the reaction [clobenpropit results in increased expression of IL16 protein] |
CTD |
PMID:12235264 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il5 |
interleukin 5 |
affects expression |
ISO |
clobenpropit affects the expression of IL5 protein |
CTD |
PMID:17346280 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions |
EXP ISO |
clobenpropit inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:12411423 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
[Dimaprit binds to and results in increased activity of HRH2 protein] which affects the expression of CD14 protein |
CTD |
PMID:14499251 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein] |
CTD |
PMID:12538815 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
ISO |
Dimaprit results in decreased expression of FOS protein [Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA; Famotidine inhibits the reaction [[Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA] |
CTD |
PMID:9187264 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Hrh2 |
histamine receptor H 2 |
multiple interactions increases activity |
ISO EXP |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dimaprit results in increased expression of HRH2 mRNA]; [Dimaprit binds to and results in increased activity of HRH2 protein] which affects the expression of CD14 protein; [Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased abundance of Cyclic AMP; [Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA; Dimaprit binds to and results in increased activity of HRH2 protein; Dimaprit inhibits the reaction [HRH2 protein promotes the reaction [Colforsin results in increased abundance of Cyclic AMP]]; Dimaprit inhibits the reaction [HRH2 protein promotes the reaction [Dinoprostone results in increased abundance of Cyclic AMP]]; Famotidine inhibits the reaction [[Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA]; HRH2 protein promotes the reaction [Dimaprit results in increased expression of IL16 protein] Dimaprit binds to and results in increased activity of HRH2 protein; Ranitidine inhibits the reaction [Dimaprit binds to and results in increased activity of HRH2 protein] Dimaprit results in increased activity of HRH2 protein Dimaprit binds to and results in increased activity of HRH2 protein; HRH2 protein promotes the reaction [Dimaprit results in increased expression of IL6 mRNA] |
CTD |
PMID:9187264 PMID:9657254 PMID:12235264 PMID:14499251 PMID:16143415 PMID:21276809 More...
|
|
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] |
CTD |
PMID:11752121 PMID:12364868 PMID:12538815 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
affects expression multiple interactions |
ISO |
Dimaprit affects the expression of IFNG protein Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]; Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]] Dimaprit inhibits the reaction [IL18 protein results in increased expression of IFNG protein] |
CTD |
PMID:11752121 PMID:12364868 PMID:17346280 PMID:19277450 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [IL18 protein results in decreased expression of IL10 protein] |
CTD |
PMID:11752121 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il16 |
interleukin 16 |
increases expression multiple interactions |
ISO |
Dimaprit results in increased expression of IL16 protein HRH2 protein promotes the reaction [Dimaprit results in increased expression of IL16 protein] |
CTD |
PMID:12235264 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]; Dimaprit inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]; Dimaprit inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; Dimaprit inhibits the reaction [IL18 protein results in increased expression of IFNG protein]; Dimaprit inhibits the reaction [IL18 protein results in increased expression of TNF protein] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]; Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] |
CTD |
PMID:19277450 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]; Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]] |
CTD |
PMID:19277450 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
affects expression |
ISO |
Dimaprit affects the expression of IL5 protein |
CTD |
PMID:17346280 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Dimaprit results in increased expression of IL6 mRNA HRH2 protein promotes the reaction [Dimaprit results in increased expression of IL6 mRNA] |
CTD |
PMID:9657254 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Dimaprit results in decreased expression of JUN protein |
CTD |
PMID:9187264 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Dimaprit results in decreased expression of MYC protein |
CTD |
PMID:9187264 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ntf3 |
neurotrophin 3 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dimaprit results in increased expression of NTF3 protein]; [methylhistaprodifen co-treated with Dimaprit co-treated with imetit] results in increased expression of NTF3 protein; [methylhistaprodifen co-treated with Dimaprit] results in increased expression of NTF3 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dimaprit results in increased expression of NTF3 protein] |
CTD |
PMID:21276809 |
|
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Dimaprit binds to and results in increased activity of TNF protein; Dimaprit inhibits the reaction [IL18 protein results in increased expression of TNF protein]; Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Dimaprit binds to and results in increased activity of TNF protein; Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]; Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]] |
CTD |
PMID:9088875 PMID:11752121 PMID:12538815 PMID:19277450 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of CAT protein] |
CTD |
PMID:25496245 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ckb |
creatine kinase B |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]] |
CTD |
PMID:25496245 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]] |
CTD |
PMID:25496245 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GOT1 protein] |
CTD |
PMID:25496245 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GPT protein] |
CTD |
PMID:25496245 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hrh3 |
histamine receptor H3 |
multiple interactions increases activity |
ISO EXP |
imetit binds to and results in increased activity of HRH3 protein Imetit binds to Hrh3 protein; imetit inhibits the reaction [N-methylhistamine binds to Hrh3 protein] imetit results in increased activity of HRH3 protein [imetit results in increased activity of HRH3 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; ciproxifan inhibits the reaction [[imetit results in increased activity of HRH3 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]; imetit binds to and results in increased activity of HRH3 protein; Pertussis Toxin inhibits the reaction [[imetit results in increased activity of HRH3 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]; thioperamide inhibits the reaction [[imetit results in increased activity of HRH3 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]] [imetit binds to and results in increased activity of HRH3 protein] which results in increased transport of Calcium; imetit binds to and results in increased activity of HRH3 protein |
CTD RGD |
PMID:12100006 PMID:12706455 PMID:21276809 PMID:10869375 |
RGD:632981 |
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
|
|
G |
Hrh4 |
histamine receptor H4 |
multiple interactions |
ISO |
[imetit binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium; imetit binds to and results in increased activity of HRH4 protein |
CTD |
PMID:11181941 |
|
NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Ntf3 |
neurotrophin 3 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [imetit results in increased expression of NTF3 protein]; [methylhistaprodifen co-treated with Dimaprit co-treated with imetit] results in increased expression of NTF3 protein; Pertussis Toxin inhibits the reaction [imetit results in increased expression of NTF3 protein]; Staurosporine inhibits the reaction [imetit results in increased expression of NTF3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [imetit results in increased expression of NTF3 protein] |
CTD |
PMID:21276809 |
|
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
imetit inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of SOD1 protein] |
CTD |
PMID:25496245 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions decreases expression |
ISO |
Ro 31-8220 inhibits the reaction [5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate results in increased expression of ABCA1 mRNA] Ro 31-8220 results in decreased expression of ABCA1 mRNA |
CTD |
PMID:15037193 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [panaxytriol results in increased activity of AKR1C2 protein] |
CTD |
PMID:18826220 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [panaxytriol results in increased activity of AKR1C3 protein] |
CTD |
PMID:18826220 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein] |
CTD |
PMID:36925031 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein] |
CTD |
PMID:36925031 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] |
CTD |
PMID:22001173 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO EXP |
Ro 31-8220 results in increased activity of CASP3 protein Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased activity of CASP3 protein]; Ro 31-8220 inhibits the reaction [Paraoxon results in increased activity of CASP3 protein] |
CTD |
PMID:17561261 PMID:18054255 PMID:22001173 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Ro 31-8220 results in increased activity of CASP8 protein |
CTD |
PMID:18054255 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased activity of CASP9 protein] |
CTD |
PMID:22001173 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cd38 |
CD38 molecule |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [Tretinoin results in increased expression of CD38 mRNA] |
CTD |
PMID:21393419 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO EXP |
Ro 31-8220 inhibits the reaction [Formaldehyde results in increased phosphorylation of CREB1 protein]; Ro 31-8220 inhibits the reaction [Tretinoin results in increased phosphorylation of CREB1 protein] Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein] |
CTD |
PMID:15522277 PMID:16280361 PMID:22138297 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [DPP3 protein results in increased expression of NQO1 protein] |
CTD |
PMID:17360324 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [EDN1 protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:12169099 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of EGF protein] |
CTD |
PMID:12947092 PMID:16877402 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Fcer1a |
Fc epsilon receptor Ia |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [FCER1A protein results in increased expression of IL6 mRNA]; Ro 31-8220 inhibits the reaction [FCER1A protein results in increased expression of TNF mRNA] |
CTD |
PMID:16818790 |
|
NCBI chr13:85,686,099...85,692,394
Ensembl chr13:85,686,092...85,692,351
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO |
Ro 31-8220 inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]; Ro 31-8220 inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] Ro 31-8220 results in decreased expression of FOS mRNA |
CTD |
PMID:11353138 PMID:11568973 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [gingerol results in increased expression of GDF15 protein] |
CTD |
PMID:18058799 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of GJA1 protein] |
CTD |
PMID:36925031 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Grp |
gastrin releasing peptide |
multiple interactions |
ISO |
Ro 31-8220 promotes the reaction [GRP protein modified form results in increased chemical synthesis of Inositol Phosphates] |
CTD |
PMID:18313772 |
|
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases activity |
ISO |
Ro 31-8220 results in decreased activity of GSK3B protein |
CTD |
PMID:10998351 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [Acrolein results in increased expression of HMOX1 mRNA]; Ro 31-8220 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; Ro 31-8220 inhibits the reaction [Curcumin results in increased expression of HMOX1 protein] |
CTD |
PMID:18048804 PMID:18357586 PMID:26275128 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hrh1 |
histamine receptor H 1 |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Histamine results in increased expression of HRH1 mRNA] |
CTD |
PMID:18360087 |
|
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
|
|
G |
Il11 |
interleukin 11 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [Formaldehyde results in increased expression of IL11 mRNA]; Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL11 mRNA] |
CTD |
PMID:22138297 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [bufalin results in increased expression of IL1B mRNA]; Ro 31-8220 inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Ro 31-8220 inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10712238 PMID:11854442 PMID:18054255 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [FCER1A protein results in increased expression of IL6 mRNA] |
CTD |
PMID:16818790 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO EXP |
Ro 31-8220 inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] Ro 31-8220 inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:14511371 PMID:19070612 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO EXP |
Ro 31-8220 inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]; Ro 31-8220 inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA] Ro 31-8220 results in decreased expression of JUN mRNA Ro 31-8220 inhibits the reaction [EDN1 protein results in increased phosphorylation of JUN protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased expression of JUN mRNA] |
CTD |
PMID:11353138 PMID:11568973 PMID:12169099 PMID:19002563 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein] Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] Ro 31-8220 inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:10712238 PMID:12083801 PMID:16877402 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK3 protein] Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] Ro 31-8220 inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:10712238 PMID:12083801 PMID:16877402 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases activity |
EXP |
Ro 31-8220 inhibits the reaction [Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK8 protein] Ro 31-8220 results in increased activity of MAPK8 protein |
CTD |
PMID:11027531 PMID:11756236 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein] |
CTD |
PMID:11756236 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [Arachidonic Acid results in increased phosphorylation of MAPT protein] |
CTD |
PMID:12605413 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions decreases expression |
ISO |
Ro 31-8220 inhibits the reaction [Cadmium Chloride results in increased expression of MT1 mRNA]; Ro 31-8220 inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA] Ro 31-8220 results in decreased expression of MT1 mRNA |
CTD |
PMID:11551972 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [deoxynivalenol results in increased expression of NOS2 protein] |
CTD |
PMID:32416088 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [DPP3 protein results in increased expression of NQO1 protein]; Ro 31-8220 inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] |
CTD |
PMID:17360324 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nts |
neurotensin |
increases activity multiple interactions |
ISO |
Ro 31-8220 results in increased activity of NTS protein Ro 31-8220 affects the reaction [NTS protein results in increased chemical synthesis of Inositol Phosphates]; Tetradecanoylphorbol Acetate inhibits the reaction [Ro 31-8220 results in increased activity of NTS protein] |
CTD |
PMID:18313772 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased phosphorylation of PPP1R14A protein] |
CTD |
PMID:18986333 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO EXP |
Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein] Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein] |
CTD |
PMID:32416088 PMID:36925031 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCE protein] |
CTD |
PMID:32416088 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Prkcg |
protein kinase C, gamma |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCG protein] |
CTD |
PMID:32416088 |
|
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
|
|
G |
Prkci |
protein kinase C, iota |
decreases activity |
ISO |
Ro 31-8220 results in decreased activity of PRKCI protein |
CTD |
PMID:14511371 |
|
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Ro 31-8220 inhibits the reaction [NCX 4040 results in increased expression of PTGS2 protein] Ro 31-8220 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] |
CTD |
PMID:11854442 PMID:19576865 PMID:32416088 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased expression of RHOA protein modified form] |
CTD |
PMID:18986333 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rnf187 |
ring finger protein 187 |
multiple interactions decreases stability |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ro 31-8220 results in decreased stability of RNF187 protein] |
CTD |
PMID:25851810 |
|
NCBI chr10:43,709,493...43,715,392
Ensembl chr10:43,702,357...43,716,157
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
decreases activity |
EXP |
Ro 31-8220 results in decreased activity of RPS6KA5 protein |
CTD |
PMID:15522277 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [Niacin results in increased expression of SCARB1 mRNA] |
CTD |
PMID:15037193 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Sftpb |
surfactant protein B |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Adenosine Triphosphate results in increased secretion of SFTPB protein]; Ro 31-8220 inhibits the reaction [Adenosine-5'-(N-ethylcarboxamide) results in increased secretion of SFTPB protein]; Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SFTPB protein] |
CTD |
PMID:11704537 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpc |
surfactant protein C |
multiple interactions |
EXP |
Ro 31-8220 inhibits the reaction [Adenosine Triphosphate results in increased secretion of SFTPC protein]; Ro 31-8220 inhibits the reaction [Adenosine-5'-(N-ethylcarboxamide) results in increased secretion of SFTPC protein]; Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SFTPC protein] |
CTD |
PMID:11704537 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] |
CTD |
PMID:17360324 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [FCER1A protein results in increased expression of TNF mRNA] |
CTD |
PMID:16818790 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
Ro 31-8220 inhibits the reaction [decitabine results in increased expression of TNFSF10 protein] |
CTD |
PMID:17283156 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
EXP |
Ro 31-8220 results in decreased expression of VEGFA mRNA |
CTD |
PMID:12590138 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
S-methylthiocitrulline inhibits the reaction [EDN1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:16380457 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions decreases activity |
EXP ISO |
[S-methylthiocitrulline results in decreased activity of NOS1 protein] which affects the abundance of Sodium [S-methylthiocitrulline results in decreased activity of NOS1 protein] which affects the susceptibility to Methamphetamine |
CTD |
PMID:11006970 PMID:12511180 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
multiple interactions |
EXP |
S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased activity of SLC18A2 protein]; S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] |
CTD |
PMID:17683483 |
|
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
|
|